Global Patient Biomarker Survey – by 31 Jan 2023
The ABC Global Alliance has partnered with AstraZeneca to create a survey that aims to understand the level of knowledge people living with advanced/metastatic breast cancer have about breast cancer, and how healthcare teams discuss this with their patients. The data captured will be used to help inform approaches to enhance patient education on breast cancer.
This survey is intended only for completion by patients living with advanced/metastatic breast cancer, and all data collected will be anonymous.
Please help by completing the survey – See the PDF and link for the survey in your country in Further Information column.
Deadline 31 Jan 2023